Ibalizumab
id:
ibalizumab-169-2830296
title:
Ibalizumab
text:
Ibalizumab, sold under the brand name Trogarzo, is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. Post-attachment inhibitors are a subclass of HIV drugs called entry inhibitors. On March 6, 2018, the U.S. Food and Drug Administration (FDA) approve
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ibalizumab
date created:
2007-07-08T14:28:03Z
date modified:
2024-08-31T07:16:58Z
main entity:
{"identifier":"Q3791531","url":"https://www.wikidata.org/entity/Q3791531"}
image:
fields total:
13
integrity:
15